Israel · Delayed Price · Currency is ILS · Price in ILA Compugen Statistics
Total Valuation
Compugen has a market cap or net worth of ILS 494.79 million. The enterprise value is 226.61 million.
| Market Cap | 494.79M |
| Enterprise Value | 226.61M |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 93.54M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.34% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 14.31% |
| Float | 91.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.65 |
| PB Ratio | 3.41 |
| P/TBV Ratio | 3.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.48 |
| EV / Sales | 10.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.38 |
| Quick Ratio | 4.38 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.95% and return on invested capital (ROIC) is -36.52%.
| Return on Equity (ROE) | -52.95% |
| Return on Assets (ROA) | -18.18% |
| Return on Invested Capital (ROIC) | -36.52% |
| Return on Capital Employed (ROCE) | -41.52% |
| Revenue Per Employee | 308,872 |
| Profits Per Employee | -1.24M |
| Employee Count | 74 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Compugen has paid 192,044 in taxes.
| Income Tax | 192,044 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.18% in the last 52 weeks. The beta is 2.82, so Compugen's price volatility has been higher than the market average.
| Beta (5Y) | 2.82 |
| 52-Week Price Change | -18.18% |
| 50-Day Moving Average | 522.47 |
| 200-Day Moving Average | 563.60 |
| Relative Strength Index (RSI) | 48.68 |
| Average Volume (20 Days) | 39,384 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.50 |
Income Statement
In the last 12 months, Compugen had revenue of ILS 22.86 million and -91.45 million in losses. Loss per share was -0.99.
| Revenue | 22.86M |
| Gross Profit | 1.70M |
| Operating Income | -106.62M |
| Pretax Income | -91.26M |
| Net Income | -91.45M |
| EBITDA | -104.98M |
| EBIT | -106.62M |
| Loss Per Share | -0.99 |
Balance Sheet
The company has 285.05 million in cash and 9.75 million in debt, giving a net cash position of 275.29 million.
| Cash & Cash Equivalents | 285.05M |
| Total Debt | 9.75M |
| Net Cash | 275.29M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 145.11M |
| Book Value Per Share | 1.55 |
| Working Capital | 227.26M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 7.43% |
| Operating Margin | -466.46% |
| Pretax Margin | -399.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Compugen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.34% |
| Shareholder Yield | -3.34% |
| Earnings Yield | -18.48% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |